Greg Mitchell is a seasoned intellectual property advisor with a particular focus in the life sciences, biopharmaceutical and clean tech sectors. With extensive experience in developing and implementing global patent strategies, he provides comprehensive IP counseling across diverse technologies. Greg has developed and implemented IP strategies for numerous IP-value driven companies, many of which have subsequently had M&A or licensing deals worth hundreds of millions or billions of dollars.

Greg’s strong technical background and practical business acumen facilitate timely and strategic advice that is always focused on advancing clients’ business goals. Clients look to his experience and in-depth knowledge of science, patent strategy, due diligence and corporate transactions — skillsets that allow the agile navigation of the biopharmaceutical sector’s complexities, empowering informed decisions while mitigating legal risks.